Transforming growth factor β1 increases the expressions of high molecular weight tropomyosin isoforms and vinculin and suppresses the transformed phenotypes in human lung carcinoma cells

Cancer Letters

Volumn 121, Issue 1, 1997, Pages 31-37

  Tada, Akio ^a   Kato, Hirohisa ^b   Takenaga, Keizo ^c   Hasegawa, Shuji ^d  

^a Chiba City Health Center   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c CHIBA CANCER CENTER   (Japan)

^d Chiba City Institute of Health and Environment   (Japan)

Author keywords

TGF 1; Transformed phenotypes; Tropomyosin; Vinculin

Indexed keywords

ISOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TROPOMYOSIN; VINCULIN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUNG CARCINOMA; MICROFILAMENT; PRIORITY JOURNAL; PROTEIN INDUCTION;

ACTINS; ANIMALS; BLOTTING, WESTERN; CARCINOMA; CELL ADHESION; CELL SIZE; CELL TRANSFORMATION, NEOPLASTIC; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG NEOPLASMS; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; TRANSFORMING GROWTH FACTOR BETA; TROPOMYOSIN; TUMOR CELLS, CULTURED; VERO CELLS; VINCULIN;

EID: 0030735234     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00319-4     Document Type: Article

References (29)

1. Roberts A.B., Flanders K.C., Kondaiah P., Thompson N.L., Van-Obberghen-Schilling E., Wakefield L., Rossi P., de-Crombugghe B., Heine U., Sporn M.B. Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Prog. Horm. Res. 44:1988;157-197.
2. Massague J. The transforming growth factor-β family. Annu. Rev. Cell. Biol. 98:1990;116-127.
3. Kim S.-J., Lee H.-D., Robbins P.D., Busam K., Sporn M.B., Roberts A.B. Regulation of transforming growth factor β1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc. Natl. Acad. Sci. USA. 88:1991;3052-3056.
4. Slingerland J.M., Hengst L., Pan C.-H., Alexander D., Stampfer M.R., Reed S.I. A novel inhibitor of cyclin-Cdk activity detected in transforming factor β-arrested epithelial cells. Mol. Cell. Biol. 14:1994;3683-3694.
5. 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes. Cell Growth Diff. 3:1992;693-704.
6. Roberts A.B., Anzano M.A., Wakefield L.M., Roche N.S., Stern D.F., Sporn M.B. Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA. 82:1985;119-123.
7. Kubota S., Fridmann R., Yamada Y. Transforming growth factor-β suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloprotease. Biochem. Biophys. Res. Commun. 176:1991;129-136.
8. Merzak A., McCrea S., Koocheckpour S., Pilkington G.J. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. Br. J. Cancer. 70:1994;199-203.
9. Hsu S., Huang F., Hafez M., Winawer S., Friedman E. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression. Cell Growth Diff. 5:1994;267-275.
10. Spearman M., Taylor W.R., Greenberg A.H., Wright J.A. Antisense oligodeoxyribonucleotide inhibition of TGF-beta 1 gene expression and alterations in the growth and malignant properties of mouse fibrosarcoma cells. Gene. 149:1994;25-29.
11. Serra R., Carbonetto S., Lord M., Isom H.C. Transforming growth factor β1 suppresses transformation in hepatocytes by regulating α1, β1 integrin expression. Cell Growth Diff. 5:1994;509-517.
12. Arnoletti J.P., Albo D., Granick M.S., Solomon M.P., Castiglioni A., Rothman V.L., Tuszynski G.P. Thombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB231 breast cancer cells. Cancer. 76:1995;998-1005.
13. Button E., Shapland C., Lawson D. Actin, its associated proteins and metastasis. Cell Motil. Cytoskeleton. 30:1995;247-251.
14. Raz A., Geiger B. Altered organization of cell-substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities. Cancer Res. 42:1982;5183-5190.
15. Cooper H.L., Feuerstein N., Noda M., Bassin R.H. Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes. Mol. Cell. Biol. 5:1985;972-983.
16. Takenaga K., Nakamura Y., Sakiyama S. Differential expression of a tropomyosin isoform in low- and high-metastatic Lewis lung carcinoma cells. Mol. Cell. Biol. 8:1988;3934-3937.
17. Takenaga K., Nakamura Y., Sakiyama S. Suppression of synthesis of tropomyosin isoform 2 in metastatic v-Ha-ras-transformed NIH3T3 cells. Biochem. Biophys. Res. Commun. 157:1988;1111-1116.
18. Bhattacharya B., Prasad G.L., Valverius E.M., Salomon D.S., Cooper H.L. Tropomyosins of human mammary epithelial cells; consistent defects of expression in mammary carcinoma cell lines. Cancer Res. 50:1990;2105-2112.
19. Rodriguez Fernandez J.L., Geiger B., Salomon D., Sabanay I., Zöller M., Ben-Ze'ev A. Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA. J. Cell Biol. 119:1992;427-438.
20. Glück U., Kwiatkowski D.J., Ben-Ze'ev A. Suppression of tumorigenicity in simian virus 40-transformed 3T3 cells transfected with α-actinin cDNA. Proc. Natl. Acad. Sci. USA. 90:1993;383-387.
21. Prasad G.L., Fuldner R.A., Cooper H.L. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc. Natl. Acad. Sci. USA. 90:1993;7039-7043.
22. Braverman R.H., Cooper H.L., Lee H.-S., Prasad G.L. Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences. Oncogene. 13:1996;537-545.
23. Masuda A., Takenaga K., Kondoh F., Fukami H., Utsumi K., Okayama H. Role of a signal transduction pathway which controls disassembly of microfilament bundles and suppression of high-molecular-weight tropomyosin expression in oncogenic transformation of NRK cells. Oncogene. 12:1996;2081-2088.
24. Rodriguez Fernandez J.L., Geiger B., Salomon D., Ben-Ze'ev A. Suppression of vinculin expression by antisense transfection confers changes in cell morphology, motility, and anchorage-dependent growth of 3T3 cells. J. Cell Biol. 122:1993;1285-1294.
25. Glück U., Ben-Ze'ev A. Modulation of alpha-actinin levels affects cell motility and confers tumorigenicity on 3T3 cells. J. Cell Sci. 107:1994;1773-1782.
26. Nakamura Y., Sakiyama S., Takenaga K. Suppression of syntheses of high molecular weight nonmuscle tropomyosins in macrophages. Cell Motil. Cytoskeleton. 31:1995;273-282.
27. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:1987;3239-3245.
28. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:1994;61-65.
29. Hashimoto Y., Shindo-Okada N., Tani M., Takeuchi K., Toma H., Yokota J. Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. Cancer Res. 56:1996;5266-5271.